Examkin

Soru

Zorluk: ZorMedical History Evaluation

A 56-year-old woman is brought to the emergency department by her husband due to progressive confusion, worsening hand tremors, and an unsteady gait over the past week. She has a history of bipolar I disorder, which has been well controlled on a stable regimen of lithium carbonate for the past five years. Her medical history also includes essential hypertension, hyperlipidemia, and severe osteoarthritis. Vital signs are within normal limits. Physical examination reveals coarse resting tremors, generalized hyperreflexia, and truncal ataxia. A basic metabolic panel is notable for a serum creatinine of 1.4 mg/dL, elevated from a baseline of 0.9 mg/dL three months ago. Her serum lithium level is 2.2 mEq/L (therapeutic range: 0.6-1.2 mEq/L). Which of the following recent changes in the patient's history are the most likely precipitants of her acute clinical syndrome? (Select two that apply)

  1. Commencing daily use of over-the-counter naproxen for osteoarthritis flaresCevap
  2. Filling a new prescription for lisinopril to optimize blood pressure managementCevap
  3. C
    Adding amlodipine to her regimen as a replacement antihypertensive agent
  4. D
    Discontinuing her lipid-lowering medication due to mildly elevated serum aminotransferases
  5. E
    Sustaining an embedded tick bite during a recent hiking trip to an endemic area

Cevap

The critical historical elements are the recent initiation of naproxen and the new prescription for lisinopril, as both drugs drastically reduce renal lithium clearance.
The patient presents with classic signs of acute lithium toxicity accompanied by an elevated serum lithium level and acute kidney injury. Because lithium is almost entirely excreted by the kidneys and is reabsorbed in the proximal tubule alongside sodium, any factor that decreases glomerular filtration rate or enhances proximal sodium reabsorption will increase lithium levels. Nonsteroidal anti-inflammatory drugs (such as naproxen) and angiotensin-converting enzyme inhibitors (such as lisinopril) alter renal blood flow and enhance proximal tubular reabsorption of lithium. Eliciting a history of recent initiation of either of these agents is critical, as they drastically reduce lithium clearance and precipitate toxicity.

Adım Adım Çözüm

1
Analyze the clinical presentation and laboratory results.
The patient exhibits classic signs of lithium toxicity (coarse tremors, ataxia, hyperreflexia, confusion) confirmed by a toxic serum level of 2.2 mEq/L and an acute rise in serum creatinine.
Establishing the definitive diagnosis (acute lithium toxicity with acute kidney injury) focuses the medical history evaluation on identifying recent precipitating factors.
2
Evaluate the mechanism of lithium clearance.
Lithium is cleared almost exclusively by the kidneys, heavily relying on glomerular filtration and proximal tubular reabsorption alongside sodium.
Understanding the pharmacokinetic pathways helps identify which xenobiotics or physiological changes would alter its clearance.
3
Identify interacting medications from the provided history options.
NSAIDs (naproxen) and ACE inhibitors (lisinopril) are identified as agents that alter renal hemodynamics, increasing proximal reabsorption of lithium and causing toxicity.
Differentiating these interacting agents from non-interacting agents (like amlodipine) is essential for accurate diagnosis and management.

Anahtar Kavram

Pharmacokinetic evaluation of the medical history in patients taking lithium, specifically identifying concurrent medications that alter renal hemodynamics (NSAIDs, ACE inhibitors, thiazide diuretics) and precipitate acute toxicity.
Tahmini Süre:2m 0s
Bu soruyu puanla

Konular

Medical History Evaluation

Bu konudan daha fazla soru